Plain-English translation of NCT06939673 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called Miro3D Wound Matrix, which is made from processed pig liver tissue and shaped like a three-dimensional scaffold. Researchers want to see if applying this matrix directly to difficult-to-heal wounds—such as diabetic foot ulcers, pressure ulcers, and surgical wounds—helps them heal better when used together with standard wound care. The study will follow 20 adults for 12 weeks to measure how much the wound shrinks and whether new healthy tissue forms.
Many chronic wounds, especially those in people with diabetes or limited blood flow, are very hard to treat and heal slowly or not at all. This treatment aims to give the wound a biological scaffold that supports the body's natural healing process and works better than standard care alone.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic weekly for 12 weeks. During the first 4 weeks, the matrix will be applied to your clean wound once per week. After that, if your wound hasn't fully closed, the matrix will be reapplied every 2 weeks through week 12 or until healing is complete. At each visit, the clinic team will measure your wound size, take photographs, and assess how much healthy tissue is forming. You will also continue all standard wound care—including cleaning, dressing changes, and any compression or offloading needed—and must follow these instructions at home between visits.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States